0001242616-13-000002.txt : 20130103 0001242616-13-000002.hdr.sgml : 20130103 20130103162647 ACCESSION NUMBER: 0001242616-13-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130102 FILED AS OF DATE: 20130103 DATE AS OF CHANGE: 20130103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madison Greg CENTRAL INDEX KEY: 0001564955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 13507102 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-01-02 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001564955 Madison Greg 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 EVP, Chief Commercial Officer Stock Option 15.89 2013-01-02 4 A 0 75000 0 A 2023-01-02 Common Stock 75000 75000 D Restricted Stock Unit 2013-01-02 4 A 0 35000 0 A Common Stock 35000 35000 D Grant of common stock pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in four equal installments commencing on January 2, 2014. Not applicable. Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). Grant of restricted stock unit pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan. This grant vests in four equal annual installments commencing on January 2, 2014. Nancy R. Smith, attorney-in-fact 2013-01-03